Company Overview

Development Stage

About the Company

Nanhua Biopharmaceutical Co., Ltd. is a high-tech biopharmaceutical technology company based on stem cells and regenerative medicine, driven by clinical translational research and application of cell therapy, with a layout centered on precision medicine, assisted reproduction, and health management. Through its layout and efforts across the entire big health industry chain, it aims to build a world-class biotechnology company. Nanhua Biology has formed an outstanding scientific research team led by Nobel Prize laureates, with Harvard University postdoctoral fellows as the core force, and bringing together domestic 973/863 project experts as the foundation. The company possesses advanced cytological technology, has established * cell laminar flow culture rooms, built a scientific and efficient clinical application research system for cells, and has rich experience in clinical cell research. As a state-owned listed company with the Hunan Provincial Government as the actual controller and Hunan Caixin Financial Holdings Group as the * largest shareholder, Nanhua Biology takes "universal love for the people, benefiting the public" as its mission, deeply cultivates the biotechnology industry, and promotes a new leap in human health. Hunan Nanhua Biotechnology Co., Ltd. (hereinafter referred to as the Company) is a controlled subsidiary of Nanhua Biopharmaceutical Co., Ltd. The company has formed a top-tier scientist matrix with Academician Zhou Honghao of the Chinese Academy of Engineering as the chairman of the expert committee, Academicians of the Chinese Academy of Sciences as consultants, Harvard University postdoctoral fellows as the core force, and national 973/863 project experts as the professional combination. It also has laboratories constructed according to clinical-grade specifications and requirements and related technical personnel, possesses strong scientific research and technical strength in the fields of stem cells and tissue engineering, and has rich experience in the production and preparation, storage, health anti-aging, and clinical treatment of stem cells and immune cells.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Nanhua Biology Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 深交所

Nanhua Biology honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Nanhua Biology Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 33,002.3098万(元)
Legal Representative: 杨云
Date Established:
Credit Code: 91430000700227986F
Registered Address: 长沙市高新区岳麓西大道1698号麓谷科技创新创业园B1栋3楼

People who follow Nanhua Biology also follow

Nanhua Biology Competitors (Similar Companies)

养老服务 体外诊断/IVD 核医学 健康投资
“An enterprise focusing on the research, development and production of ”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates